These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 8807797)

  • 1. Role of gyrA mutation and loss of OprF in the multiple antibiotic resistance phenotype of Pseudomonas aeruginosa G49.
    Pumbwe L; Everett MJ; Hancock RE; Piddock LJ
    FEMS Microbiol Lett; 1996 Sep; 143(1):25-8. PubMed ID: 8807797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of multiple-antibiotic-resistant (Mar) mutants of Pseudomonas aeruginosa after serial exposure to fluoroquinolones.
    Zhanel GG; Karlowsky JA; Saunders MH; Davidson RJ; Hoban DJ; Hancock RE; McLean I; Nicolle LE
    Antimicrob Agents Chemother; 1995 Feb; 39(2):489-95. PubMed ID: 7726519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
    Jalal S; Wretlind B
    Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of gyrA mutations among 335 Pseudomonas aeruginosa strains isolated in Japan and their susceptibilities to fluoroquinolones.
    Takenouchi T; Sakagawa E; Sugawara M
    Antimicrob Agents Chemother; 1999 Feb; 43(2):406-9. PubMed ID: 9925546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
    Akasaka T; Tanaka M; Yamaguchi A; Sato K
    Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
    Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
    Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two efflux systems expressed simultaneously in multidrug-resistant Pseudomonas aeruginosa.
    Pumbwe L; Piddock LJ
    Antimicrob Agents Chemother; 2000 Oct; 44(10):2861-4. PubMed ID: 10991874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of fluoroquinolone and carbapenem susceptibilities in clinical isolates of levofloxacin-resistant Pseudomonas aeruginosa.
    Muramatsu H; Horii T; Takeshita A; Hashimoto H; Maekawa M
    Chemotherapy; 2005 May; 51(2-3):70-5. PubMed ID: 15870499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction of a gyrA plasmid for genetic characterization of fluoroquinolone-resistant Staphylococcus aureus.
    Tankovic J; Duval J; Courvalin P
    FEMS Immunol Med Microbiol; 1994 Jun; 9(1):35-9. PubMed ID: 7920462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon.
    Salma R; Dabboussi F; Kassaa I; Khudary R; Hamze M
    J Infect Chemother; 2013 Feb; 19(1):77-81. PubMed ID: 22821356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gyrA and parC genes in fluoroquinolone-resistant clinical isolates of Pseudomonas aeruginosa.
    Nakano M; Deguchi T; Kawamura T; Yasuda M; Kimura M; Okano Y; Kawada Y
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2289-91. PubMed ID: 9333065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proportion of DNA gyrase mutants among quinolone-resistant strains of Pseudomonas aeruginosa.
    Yoshida H; Nakamura M; Bogaki M; Nakamura S
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1273-5. PubMed ID: 2168149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of fluoroquinolone resistance in Pseudomonas aeruginosa isolates from canine infections.
    Teresa Tejedor M; Martín JL; Navia M; Freixes J; Vila J
    Vet Microbiol; 2003 Jul; 94(4):295-301. PubMed ID: 12829383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
    Lei YC; Wang HB; Sun ZY; Shen ZY
    Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of a putative ECF sigma factor on expression of the major outer membrane protein, OprF, in Pseudomonas aeruginosa and Pseudomonas fluorescens.
    Brinkman FS; Schoofs G; Hancock RE; De Mot R
    J Bacteriol; 1999 Aug; 181(16):4746-54. PubMed ID: 10438740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
    Lee JK; Lee YS; Park YK; Kim BS
    Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of efflux pumps and mutations in genes for topoisomerases II and IV in fluoroquinolone-resistant Pseudomonas aeruginosa strains.
    Oh H; Stenhoff J; Jalal S; Wretlind B
    Microb Drug Resist; 2003; 9(4):323-8. PubMed ID: 15000738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Broad-host-range gyrase A gene probe.
    Robillard NJ
    Antimicrob Agents Chemother; 1990 Oct; 34(10):1889-94. PubMed ID: 1963286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanisms of pandrug-resistance of Pseudomonas aeruginosa].
    Shen JL; Zhu DM; Wang MG
    Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1859-62. PubMed ID: 19040025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography.
    Matsumoto M; Shigemura K; Shirakawa T; Nakano Y; Miyake H; Tanaka K; Kinoshita S; Arakawa S; Kawabata M; Fujisawa M
    Int J Antimicrob Agents; 2012 Nov; 40(5):440-4. PubMed ID: 22884856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.